The delta variant is taking advantage of opportunities presented by some Americans who resist getting vaccinated and masking up.
Booster Shots for COVID-19 in Works
As COVID-19 cases continue to surge in the United States surges and states like Florida and Louisiana report some of their highest case counts of the entire pandemic, we’re still struggling to vaccinate people. In the past two weeks, the US has seen an 86% increase in cases, according to the New York Times, and a surge in hospitalizations is probably fast approaching. Children are being hospitalized more now than we anticipated and the delta variant is taking advantage of opportunities presented by some Americans who resist getting vaccinated and masking up. One particular question we’ve been facing is that of booster shots: Will they happen? When? And for whom? A new study cited by CIDRAP, a publication of the University of Minnesota, is shedding some light on a high risk population–organ transplant recipients. “The University of Health
Saskia v. Popescu, PhD, MPH, MA, CIC
Network researchers enrolled 120 organ transplant patients who had no history of COVID-19 infection, and who had suboptimal results from their 2 doses of Moderna vaccine. Two months after their second dose, half received another Moderna vaccine, while the remainder received a placebo. The resulting 2-month follow-up showed that patients who received a third dose had a higher likelihood of achieving satisfactory antibody levels against the SARS-CoV-2 spike protein as well as higher neutralizing antibody levels.” The authors reported that “A third dose of mRNA vaccine in transplant recipients had substantially higher immunogenicity than placebo, as determined in our analysis of both primary and secondary trial end points.” They add that “this trial had short follow-up and was not powered to detect differences in clinical outcomes. We also acknowledge that the cutoff value of 100 U per milliliter for the anti-RBD antibody level is arbitrary and is not necessarily predictive of resistance to infection.”
Vaccinations: To Mandate or Not to Mandate?
With only half the country vaccinated, we’re still racing against the spread of the delta variant and the significant surge that has caused over 124,000 cases in a single day. Vaccine mandates though are a challenging problem for employers, as many now face the decision. Airlines are now considering mandating vaccines, but it’s a controversial issue.
Ebola Outbreak in Guinea
Remember when infection preventionists and the rest of the heath care system was dealing with Ebola virus disease in 2014? Somehow that seems worlds away and yet here we are–a new outbreak of Marburg hemorrhagic fever in Guinea. CIDRAP reports that “Guinea's ministry of health (MOH) has confirmed the country’s first Marburg virus case, also marking the first in West Africa, the World Health Organization (WHO) African regional office said today in a statement.
“A few days ago, Guinea's government said the suspected case was reported from Gueckedou in the N'zerekore region near the borders of Liberia and Sierra Leone. The area—located in southern Guinea—was the epicenter of Guinea’s recent Ebola outbreak, which totaled 23 cases and 12 deaths. The event was declared over on Jun 19.” The patient sought care at a local health clinic and now is the time for control measures as viruses like Ebola can spread easily. While the world is focused on COVID-19, outbreaks like this are reminders that infectious diseases don’t stop simply during a pandemic, but rather require continued investment in public health, infection prevention, research, etc. Now is a good time to break out your Ebola plans and do a quick review of what might new updating!
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.